EMCDDA Home
  • EN
Search

Table TDI-10. Age distributions and primary drug distributions — EU summary of clients entering treatment, 2010 or most recent year available

Part (vi) New inpatient clients, primary drug distribution by age (%)

Substance<1515–1920–2425–2930–3435–3940–4445+Age knownAge not known
Opioids4.022.536.950.454.053.851.533.838621
Cocaine0.02.26.29.510.313.211.76.17240
Stimulants12.018.019.714.410.98.27.911.412976
Hypnotics and sedatives0.00.82.52.63.35.57.925.04151
Hallucinogens0.00.51.10.91.00.90.80.6810
Volatile substances28.010.01.91.41.01.11.00.32341
Cannabis 42.039.126.315.816.213.314.710.118790
Other substances 14.06.95.45.03.23.94.412.64971
Total501187216521391453849495651898910
 

Notes:

The countries supplying data are:

AT; BE; BG; HR; CY; CZ; DK; FI; FR; DE; GR; HU; IE; NL; PL; RO; SK; SE; TR; UK.

The number of treatment clients in each country is listed in Table TDI-7.

See also Table TDI-104 on distribution by country and ‘General notes for interpreting data’ on the Explanatory notes and help page.

Source:

Reitox national reports 2011 — Table TDI outpatient and inpatient treatment centres.

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

EMCDDA
Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00
Fax (351) 218 13 17 11

More contact options >>

Page last updated: Monday, 09 July 2012